ImmuneAGE Bio
About ImmuneAGE Bio
ImmuneAGE Bio is an intriguing initiative focused on drug discovery for immune system rejuvenation. Developing therapies that can rejuvenate or enhance the immune system could have profound implications for healthcare, especially in aging populations or those with compromised immune function
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Jul 2024)
- Website: immuneage.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/immuneage-bio-57463 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.